State of Wyoming’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-171
Closed -$9K – 1744
2022
Q2
$9K Buy
171
+10
+6% +$422 0.01% 1655
2022
Q1
$6K Buy
161
+34
+27% +$1.34K ﹤0.01% 1649
2021
Q4
$6K Buy
127
+32
+34% +$1.62K ﹤0.01% 1707
2021
Q3
$5K Buy
95
+85
+850% +$3.54K ﹤0.01% 1089
2021
Q2
$0 Buy
10
+5
+100% +$170 ﹤0.01% 1197
2021
Q1
$0 Buy
+5
New +$136 ﹤0.01% 530

Other funds holding LEGN

State of Wyoming's LEGN Position: Q3 2022 in Review

State of Wyoming sold out of Legend Biotech (LEGN) in Q3 2022, closing a stake of 171 shares — an estimated $9K sold.

State of Wyoming first reported a position in LEGN in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q2 2022. 159 funds tracked by Wall St. Rank hold LEGN as of Q3 2022.

  • State of Wyoming reported no remaining Legend Biotech position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 171 Legend Biotech shares in Q3 2022, an estimated $9K.
  • State of Wyoming first reported a position in Legend Biotech in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Legend Biotech position peaked at $9K in Q2 2022.
  • 159 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.